Breast cancer after ovarian cancer in BRCA mutation carriers

被引：0
|
作者：
Nanez, A. [1 ]
Powell, C. B. [2 ]
Garcia, C. [3 ]
机构：
[1] Kaiser Permanente San Francisco, San Francisco, CA USA
[2] Kaiser Permanente Northern Calif, San Francisco, CA USA
[3] Kaiser Permanente Northern Calif Gynecol Oncol Gr, San Francisco, CA USA
来源：
GYNECOLOGIC ONCOLOGY | 2020年 / 159卷
关键词：
D O I：
10.1016/j.ygyno.2020.05.440
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
552
引用
收藏
页码：256 / 256
页数：1
相关论文
共 50 条
  • [21] Modifiers of breast and ovarian cancer risks for BRCA1 and BRCA2 mutation carriers
    Milne, Roger L.
    Antoniou, Antonis C.
    ENDOCRINE-RELATED CANCER, 2016, 23 (10) : T69 - T84
  • [22] Breast Cancer Following Ovarian Cancer in BRCA Mutation Carriers (vol 149, pg 1306, 2014)
    Gangi, Alexandra
    Cass, Ilana
    Paik, Daniel
    JAMA SURGERY, 2015, 150 (02) : 183 - 183
  • [23] Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers
    Milne, Roger L.
    Osorio, Ana
    Ramon y Cajal, Teresa
    Baiget, Montserrat
    Lasa, Adriana
    Diaz-Rubio, Eduardo
    de la Hoya, Miguel
    Caldes, Trinidad
    Teule, Alex
    Lazaro, Conxi
    Blanco, Ignacio
    Balmana, Judith
    Sanchez-Olle, Gessami
    Vega, Ana
    Blanco, Ana
    Chirivella, Isabel
    Esteban Cardenosa, Eva
    Duran, Mercedes
    Velasco, Eladio
    Martinez de Duenas, Eduardo
    Tejada, Maria-Isabel
    Miramar, Maria-Dolores
    Calvo, Maria-Teresa
    Guillen-Ponce, Carmen
    Salazar, Raquel
    San Roman, Carlos
    Urioste, Miguel
    Benitez, Javier
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 119 (01) : 221 - 232
  • [24] Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers
    Roger L. Milne
    Ana Osorio
    Teresa Ramón y Cajal
    Montserrat Baiget
    Adriana Lasa
    Eduardo Diaz-Rubio
    Miguel de la Hoya
    Trinidad Caldés
    Alex Teulé
    Conxi Lázaro
    Ignacio Blanco
    Judith Balmaña
    Gessamí Sánchez-Ollé
    Ana Vega
    Ana Blanco
    Isabel Chirivella
    Eva Esteban Cardeñosa
    Mercedes Durán
    Eladio Velasco
    Eduardo Martínez de Dueñas
    María-Isabel Tejada
    María-Dolores Miramar
    María-Teresa Calvo
    Carmen Guillén-Ponce
    Raquel Salazar
    Carlos San Román
    Miguel Urioste
    Javier Benítez
    Breast Cancer Research and Treatment, 2010, 119 : 221 - 232
  • [25] No sib pair concordance for breast or ovarian cancer in BRCA1 mutation carriers
    Moller, Pal
    Maehle, Lovise
    Clark, Neal
    Apold, Jaran
    HEREDITARY CANCER IN CLINICAL PRACTICE, 2007, 5 (02) : 67 - 71
  • [26] Risk of metachronous breast cancer after BRCA mutation-associated ovarian cancer
    Domchek, Susan M.
    Jhaveri, Komal
    Patil, Sujata
    Stopfer, Jill E.
    Hudis, Clifford
    Powers, Jacquelyn
    Stadler, Zsofia
    Goldstein, Laura
    Kauff, Noah
    Khasraw, Mustafa
    Offit, Kenneth
    Nathanson, Katherine L.
    Robson, Mark
    CANCER, 2013, 119 (07) : 1344 - 1348
  • [27] No Sib Pair Concordance for Breast or Ovarian Cancer in BRCA1 Mutation Carriers
    Pål Møller
    Lovise Mæhle
    Neal Clark
    Jaran Apold
    Hereditary Cancer in Clinical Practice, 5
  • [28] Breast cancer in BRCA mutation carriers: medical treatment
    Milani, Andrea
    Geuna, Elena
    Zucchini, Giorgia
    Aversa, Caterina
    Martinello, Rossella
    Montemurro, Filippo
    MINERVA GINECOLOGICA, 2016, 68 (05): : 557 - 565
  • [29] Costs of breast cancer surveillance in BRCA mutation carriers
    Kamm, Y. J. L.
    Boetes, C.
    Adang, E. M. M.
    Bult, P.
    Bonenkamp, H. J.
    Hoogerbrugge, N.
    EJC SUPPLEMENTS, 2008, 6 (07): : 94 - 95
  • [30] Pregnancy after breast cancer in BRCA1/2 mutation carriers
    Jelena Maksimenko
    Arvīds Irmejs
    Jānis Gardovskis
    Hereditary Cancer in Clinical Practice, 20
12345